Figure 1.
The common treatment protocol of CAR T-cell therapy for relapsed/refractory acute lymphoblastic leukemia (R/R ALL). Challenges including access, adverse events, primary resistance and relapse are present in different treatment procedures.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.